NASDAQ · WAY

Waystar Holding Corp.

$23.13 +$0.61 (+2.73%) 1D After hours
Charting by TradingView

Key Metrics

$4.32B
Market cap
34.24×
P/E · TTM
$1.16B
Revenue · TTM
$126.10M
Net income
EPS · TTM $0.70
Dividend yield —
Free cash flow $293.96M
Beta · 1Y 0.62
EBITDA · TTM $333.89M
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 22
    From its Mar 4 high, the share price fell 36%.

    Peak close $26.93 on Mar 4; trough close $17.31 on Jun 22. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -36%
  • Jun 1
    The stock moved +10.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 1
  • Apr 30
    The stock moved -15.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.32B
Enterprise value$5.63B
Shares outstanding191.8M
52-wk range$17.26 – $41.47
Avg volume · 20D2.0M
Net cash −$1.31B
Book value / share$21.79
IndustryServices-Computer Integrated Systems Design
ExchangeNASDAQ
About Waystar Holding Corp.
IPO dateJun 7, 2024
Employees340

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E34.24
P/S3.73
P/FCF14.69
EV/EBITDA16.86
EV/Sales4.87
Graham №$18.50

Profitability

Gross —
Operating 16.0%
Net 10.9%
FCF 25.4%
ROE / ROIC 3.6% · 2.4%

Financial Health

Current ratio1.76
Quick ratio—
Debt / equity0.37
Debt / EBITDA 4.40
Net cash −$1.31B
Working capital$166.65M

Cash Flow · TTM

Operating CF $330.34M
Capex −$36.38M
Free cash flow $293.96M
Buybacks —
Dividends paid —
Shareholder yield —

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

1.7
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$18.50 vs $23.13
Trades 1.3× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings